{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyperinsulinism-hyperammonemia","columns":[{"gene":"","key":"population-c61a730fc7d422b099a6","label":"Hyperinsulinemic hypoglycemia, familial, 6","mondoId":"MONDO:0011717","onsetQualifier":null,"originColumnKey":"MONDO:0011717/OMIM:606762","originalViews":[{"key":"MONDO:0011717/OMIM:606762","label":"Hyperinsulinemic hypoglycemia, familial, 6","scopeLabel":"OMIM:606762","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["14c6c6d3c20f479026a7b79c85f0381b4a565469995d3682febe73c28f556f45","1a4e44969804b15845372539119519819ae4924c4e71e8f460600ce687e741a9","41729a753a2cfb7c20a08461dc7b8b90c9c3e25c136a228a3ef48238dafd2452","715da939e91632e626264a19ef0fd642b8d3a14b487bbbe678e7fd41742e770b","aa1fa15beee4ca6a5589685a7035879f2ec6135e52504bdc5ae25235ffdc4e66","e263dc770d5d602c0e1cecec0b0844d59b64baf92e0b99fbad01922ff856a4a7","f43aa630ed3fad058a150befab415db92539887769fa4331f4cf9afcedd119b0"],"recordQualifiers":{},"scopeLabel":"OMIM:606762","sourceIds":["OMIM:606762"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-7bdc048dba655cd0384e","label":"Hyperinsulinism-hyperammonemia syndrome","mondoId":"MONDO:0011717","onsetQualifier":null,"originColumnKey":"MONDO:0011717/ORPHA:35878","originalViews":[{"key":"MONDO:0011717/ORPHA:35878","label":"Hyperinsulinism-hyperammonemia syndrome","scopeLabel":"ORPHA:35878","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05f9f54e79afb6527bb89779e711b8c6e11a7dd730bedad076b86cbc4ec40fd5","1019f7e6bf86fb86540babcdcfe0b3e3436f11e5ec8995b61c22c72da6837280","31a31e5273a47b78201f7eb7b34aaccaf0e981fe4d513dcd87ea76bbbe189cfa","31feb3a6eed5f26ecfddaaa501a10c2c110926e65e13a8cbcee83292a0a7d3f0","389fbfbdfe07ce2ea587ab3b28820d553914006229ab76d4582337d71030a1a6","4a78e82ce4a0351728d2b92694d04723c09939500af99cb4521f08ab2569fe8e","4e30302d56ff8489b861559f312ed0e510de1495b5178eabfcdd6eee1af996d0","61a3ca56a87a0daf2a35f38898cb983bd7521f8566551f085ba6a67ec9e28f39","730f209ae4d2ee1cbe935f89f2194115ee31ecd59296a2f1b930b58001c57e9f","8035ae732b56b425244d3e52bbe3593e0542f2ed369efa7e92c1db2270b7a4fa","c330294d1ad77baea7a724e53161bc06b735ae9b7ec3fe333cac69f5a97cfa5d","cd32ca3a7b7bbc9e3e6fba501aa36f4211c2e9a6eeeaa9bb42e8c6152df4f160"],"recordQualifiers":{},"scopeLabel":"ORPHA:35878","sourceIds":["ORPHA:35878"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c61a730fc7d422b099a6","population-7bdc048dba655cd0384e"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0006476","HP:0008162","HP:0007018","HP:0011198","HP:0001508","HP:0008283","HP:0002121"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":4,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"orphanet":12,"published":7}},"features":[{"hpoId":"HP:0006476","label":"Abnormality of the pancreatic islet cells","primary":true},{"hpoId":"HP:0008162","label":"Asymptomatic hyperammonemia","primary":true},{"hpoId":"HP:0007018","label":"Attention deficit hyperactivity disorder","primary":true},{"hpoId":"HP:0011198","label":"EEG with generalized epileptiform discharges","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0008283","label":"Fasting hyperinsulinemia","primary":true},{"hpoId":"HP:0002121","label":"Generalized non-motor (absence) seizure","primary":true},{"hpoId":"HP:0002197","label":"Generalized-onset seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000825","label":"Hyperinsulinemic hypoglycemia","primary":false},{"hpoId":"HP:0001325","label":"Hypoglycemic coma","primary":false},{"hpoId":"HP:0002173","label":"Hypoglycemic seizures","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0002342","label":"Moderate intellectual disability","primary":false},{"hpoId":"HP:0012051","label":"Reactive hypoglycemia","primary":false},{"hpoId":"HP:0001328","label":"Specific learning disability","primary":false}],"ledeHtml":"A rare diffuse form of congenital hyperinsulinism characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), chronic hyperammonemia and recurrent episodes of hypoglycemia induced by fasting and protein rich meals. Epilepsy and cognitive deficit, which are unrelated to hypoglycemia but possibly related to the chronic hyperammonemia, may also occur. This disorder is usually responsive to diazoxide treatment.","mondoId":"MONDO:0011717","node":{"canonicalSlug":"hyperinsulinism-hyperammonemia","comparisons":[{"documentSha256":"694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2","key":"legacy-hyperinsulinemic-hypoglycemia","kind":"legacy","label":"hyperinsulinemic hypoglycemia","memberIds":["MONDO:0005803","MONDO:0009734","MONDO:0011153","MONDO:0011236","MONDO:0011717","MONDO:0012381","MONDO:0012382","MONDO:0012396","MONDO:0016988","MONDO:0017183","MONDO:0017184","MONDO:0017185","MONDO:0017189","MONDO:0017935","MONDO:0018465","MONDO:0019334","MONDO:0859362"],"mondoId":"MONDO:0005803","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperinsulinemic-hypoglycemia.694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hyperinsulinism-hyperammonemia syndrome","originalSourceId":"ORPHA:35878","paragraphs":["A rare diffuse form of congenital hyperinsulinism characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), chronic hyperammonemia and recurrent episodes of hypoglycemia induced by fasting and protein rich meals. Epilepsy and cognitive deficit, which are unrelated to hypoglycemia but possibly related to the chronic hyperammonemia, may also occur. This disorder is usually responsive to diazoxide treatment."],"rawAttribution":"MONDO:0011717","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:52Z","upstream":"MONDO:0011717","url":"https://rarediseases.info.nih.gov/diseases/9931"},"ownColumnKeys":["population-c61a730fc7d422b099a6","population-7bdc048dba655cd0384e"],"publication":"published","relationships":[{"kind":"parent","label":"diazoxide-sensitive diffuse hyperinsulinism","mondoId":"MONDO:0015624","slug":null},{"kind":"parent","label":"urea cycle disorder or inherited hyperammonemia","mondoId":"MONDO:0800153","slug":"urea-cycle-disorder-or-inherited-hyperammonemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"05f9f54e79afb6527bb89779e711b8c6e11a7dd730bedad076b86cbc4ec40fd5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002197","is_excluded":false,"label":"Generalized-onset seizure","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1019f7e6bf86fb86540babcdcfe0b3e3436f11e5ec8995b61c22c72da6837280","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"14c6c6d3c20f479026a7b79c85f0381b4a565469995d3682febe73c28f556f45","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":"4/5","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1a4e44969804b15845372539119519819ae4924c4e71e8f460600ce687e741a9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"31a31e5273a47b78201f7eb7b34aaccaf0e981fe4d513dcd87ea76bbbe189cfa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31feb3a6eed5f26ecfddaaa501a10c2c110926e65e13a8cbcee83292a0a7d3f0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002121","is_excluded":false,"label":"Generalized non-motor (absence) seizure","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"389fbfbdfe07ce2ea587ab3b28820d553914006229ab76d4582337d71030a1a6","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008283","is_excluded":false,"label":"Fasting hyperinsulinemia","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"41729a753a2cfb7c20a08461dc7b8b90c9c3e25c136a228a3ef48238dafd2452","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":"0/5","hpo_id":"HP:0006476","is_excluded":true,"label":"Abnormality of the pancreatic islet cells","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4a78e82ce4a0351728d2b92694d04723c09939500af99cb4521f08ab2569fe8e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012051","is_excluded":false,"label":"Reactive hypoglycemia","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e30302d56ff8489b861559f312ed0e510de1495b5178eabfcdd6eee1af996d0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008162","is_excluded":false,"label":"Asymptomatic hyperammonemia","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61a3ca56a87a0daf2a35f38898cb983bd7521f8566551f085ba6a67ec9e28f39","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002342","is_excluded":false,"label":"Moderate intellectual disability","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"715da939e91632e626264a19ef0fd642b8d3a14b487bbbe678e7fd41742e770b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001325","is_excluded":false,"label":"Hypoglycemic coma","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"730f209ae4d2ee1cbe935f89f2194115ee31ecd59296a2f1b930b58001c57e9f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011198","is_excluded":false,"label":"EEG with generalized epileptiform discharges","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8035ae732b56b425244d3e52bbe3593e0542f2ed369efa7e92c1db2270b7a4fa","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"aa1fa15beee4ca6a5589685a7035879f2ec6135e52504bdc5ae25235ffdc4e66","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c330294d1ad77baea7a724e53161bc06b735ae9b7ec3fe333cac69f5a97cfa5d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001328","is_excluded":false,"label":"Specific learning disability","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd32ca3a7b7bbc9e3e6fba501aa36f4211c2e9a6eeeaa9bb42e8c6152df4f160","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35878","disease_name":"Hyperinsulinism-hyperammonemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007018","is_excluded":false,"label":"Attention deficit hyperactivity disorder","onset_id":null,"reference":"ORPHA:35878","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e263dc770d5d602c0e1cecec0b0844d59b64baf92e0b99fbad01922ff856a4a7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002173","is_excluded":false,"label":"Hypoglycemic seizures","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f43aa630ed3fad058a150befab415db92539887769fa4331f4cf9afcedd119b0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606762","disease_name":"Hyperinsulinemic hypoglycemia, familial, 6","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0008162","is_excluded":false,"label":"Asymptomatic hyperammonemia","onset_id":null,"reference":"PMID:10636977","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9931\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011717\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0011717</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare diffuse form of congenital hyperinsulinism characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), chronic hyperammonemia and recurrent episodes of hypoglycemia induced by fasting and protein rich meals. Epilepsy and cognitive deficit, which are unrelated to hypoglycemia but possibly related to the chronic hyperammonemia, may also occur. This disorder is usually responsive to diazoxide treatment.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9931\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hyperinsulinism-hyperammonemia","sourceDocuments":[{"name":"GARD: Hyperinsulinism-hyperammonemia syndrome","reviewed":null,"source_release":"2026-10-25T03:40:52Z","url":"https://rarediseases.info.nih.gov/diseases/9931"},{"name":"MONDO: hyperinsulinism-hyperammonemia syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011717"}],"sourceNote":"","synonyms":["GDH hyperinsulinism","GLUD1 hyperinsulinism","glutamate dehydrogenase 1 hyperinsulinism","HA/hi syndrome","HHF6","hi/HA syndrome","hyperinsulinemic hypoglycemia familial 6","hyperinsulinemic hypoglycemia, familial, 6","hyperinsulinemic hypoglycemia, familial, type 6","hyperinsulinism hyperammonemia syndrome","hyperinsulinism-hyperammonemia syndrome","hyperinsulinism/hyperammonemia syndrome"],"takeawayHtml":"","title":"hyperinsulinism-hyperammonemia syndrome"},"schemaVersion":1}
